4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

10 - 11 March 2020 | London - UK
CONFERENCE SPEAKERS
Advisors
Petter Bjorquist
Petter Bjorquist
CEO,
Verigraft


PhD in Biology/Biochemistry from Gothenburg University. 50 + publications in peer reviewed journals, several book chapters and patents. Ten years within AstraZeneca R&D in Cardiovascular Diseases, twelve years at Cellartis/Cellectis as VP Regenerative Medicine, responsible for e.g. the major collaboration with Novo Nordisk on development of a human embryonic stem cell derived beta cell treatment for diabetes. Also, responsible for development of human pluripotent stem cell derived cardiomyocytes and hepatocytes. As of February 2014, CEO of VERIGRAFT AB, a pioneering company within tissue engineering and advanced regenerative medicine for use in treatment of cardiovascular, neuronal and other diseases.


Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Chief Operating Officer,
MarketsandMarkets


Shailendra Singh (Shelly) is Chief Operating Officer of MnM and a member of its board. He focuses on global sales and client services functions, as well as commercial optimization at MarketsandMarkets. He has years of expe¬rience in global delivery and outsourcing sector in the IT/ Consulting/Analytics/Big Data sectors. Prior to MnM, he was leading the global sales, client services and commercial ef¬fectiveness functions for Mu Sigma, a unicorn company and a leading global provider of Decision Sciences and Big Data analytics solutions.


Petter Bjorquist
Petter Bjorquist
CEO,
Verigraft


PhD in Biology/Biochemistry from Gothenburg University. 50 + publications in peer reviewed journals, several book chapters and patents. Ten years within AstraZeneca R&D in Cardiovascular Diseases, twelve years at Cellartis/Cellectis as VP Regenerative Medicine, responsible for e.g. the major collaboration with Novo Nordisk on development of a human embryonic stem cell derived beta cell treatment for diabetes. Also, responsible for development of human pluripotent stem cell derived cardiomyocytes and hepatocytes. As of February 2014, CEO of VERIGRAFT AB, a pioneering company within tissue engineering and advanced regenerative medicine for use in treatment of cardiovascular, neuronal and other diseases.


Ryan Guest
Ryan Guest
Director Cell Production,
Immetacyte Ltd


Ryan Guest is a Director Cell Production at Immetacyte Ltd (CTL). He has more than a decade of experience in the design, development and implementation of cGMP cell therapy manufacturing and two decades of experience of working in the field of adoptive T cell therapy (TIL, CAR, TCR). Ryan leads, Immetacyte’s partnerships with NHS partners, academic & industry in designing cell therapy manufacturing processes, QC & regulatory packages to deliver high quality cell based AT(I)MPs to enable healthcare organisations to treat patients. This has been based on Immetacyte’s early adoption in the design and implementation of clean room free technologies, back in 2010, enabling increased parallel cellular therapy product manufacturing. He also has a wealth of experience in designing and setting up sophisticated, state-of-the-art, PQS systems


Damian Marshall
Damian Marshall
Director New Technology,
Cell and Gene Therapy Catapult



Cheryl Askew
Cheryl Askew
Director of Regulatory Affairs,
CARsgen Therapeutics



John Bridgeman
John Bridgeman
Director of Cell Therapy Research,
Immetacyte Ltd



Susan Kimber
Susan Kimber
Professor of Stem cell & Developmental Biology,
The University of Manchester



Giuliana Vallanti
Giuliana Vallanti
Development & QC Director,
Molmed



Theoni Panagopoulou
Theoni Panagopoulou
Senior Research Fellow, Department of Biochemical Engineering,
UCL-IRIS



David Gilham
David Gilham
Vice President Research & Development,
Celyad



Karin Jennbacken
Karin Jennbacken
Team Leader, Heart Failure in vitro team,
AstraZeneca



Jelena Ruscic
Jelena Ruscic
Senior Scientist I – Process Development,
Autolous



Anders Lindahl
Anders Lindahl
Professor/Chief Physician,
University of Gothenburg



Ivan Wall
Ivan Wall
Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing,
Aston University



Andrew Sewell
Andrew Sewell
Professor, Division of Infection and Immunity,
Cardiff University



Fabio D'Agostino
Fabio D'Agostino
Venture Partner,
Claris Ventures



Marina Tarunina
Marina Tarunina
Research Director,
Plasticell Limited



Christiane Niederlaender
Christiane Niederlaender
Regulatory Consultant and Director,
AMBR Consulting



Tristan Pritchard-Meaker
Tristan Pritchard-Meaker
,
Leiden University Medical Centre